Issue link: https://beckershealthcare.uberflip.com/i/1368676
Executive Briefing: 24 Executive Briefing: • mymobility® with Apple Watch®*, a remote care management system which delivers support and guidance to patients through a connected experience and collects and monitors objective data on patients' surgical preparation and recovery. • OrthoIntel Orthopedic Intelligence Platform, which connects the pre- and post-operative data gathered by mymobility with intraoperative data from ROSA to uncover new clinical insights intended to help surgeons and care teams optimize care. For Dr. Ballard, his ASC's transition to using digital tools began with the ROSA Knee System. "In my opinion, Zimmer Biomet's Persona® Knee implants are the best in the industry, and I wasn't going to give that up just because I wanted a robotics solution. So, when ROSA Knee was introduced, it not only checked the box in terms of compatibility with Persona Knee but offered a better approach to supporting me during a knee replacement procedure than other robotic systems," Dr. Ballard said. "Very quickly, ROSA has become incredibly important to me because it actually gives me more control over the surgery, because I know what the surgery is going to look like before I start and then I continue to get real-time data to fine tune the cuts and placements." Soon after, Dr. Ballard added the mymobility remote care management system which allowed patients to use the mymobility app on their iPhone and Apple Watch to capture demographic information and activity metrics before and after surgery. That led to the adoption of OrthoIntel, the data analytics platform that combines pre and post-surgical data from mymobility and intraoperative data from ROSA Knee. "OrthoIntel sits above components like mymobility and ROSA and pulls in all of the data generated by them — so as this system pulls in more data, I will be able to get demographic information about my patient," Dr. Ballard said. "For example, I can go into the system and say, 'This is a 55-year-old male, he has this comorbidity, and this type of deformity in the joint and the system can start generating insights that will help me make better decisions for that patient, grounded in data from similar patients." Dr. Ballard then provided an example of how the benefits of ZBEdge extend beyond the operating room into the post- op follow up. "I can log in and check up on a patient that I've operated on, see their current data from mymobility — their step count and heart rate, their activity level and habits, if they've reported any pain or discomfort — and then I can also pull up, in the same place, all of the relevant data from ROSA that was captured both before and during their surgery," Dr. Ballard said. "It's incredibly helpful to then show the patient 'Here your hip-knee-ankle axis was 14 degrees and now we've made it 3 degrees and connect that directly to their lived experience recovering from the surgery and regaining their mobility." The future of integrated technology in the ASC For Dr. Ballard, the most exciting thing about ZBEdge — and the role of technology in the ASC, more generally — is the promise that it holds as data analysis and data sources become more robust and more commonplace. "I know that one day — not far from now — I'll be able to go into an operating room and use OrthoIntel to look at not only the case at hand but also demographic data from similar patients — age, sex, anatomy, comorbidities — and get an informed recommendation on what will be the best course of action for the patient I'm operating on. But what's maybe more exciting is that ZBEdge is constantly growing and expanding as new innovations are integrated into the system — and that means that a surgeon who uses it will be constantly elevating their approach to joint replacements and constantly raising the bar in terms of outcomes and experience," Dr. Ballard said. "And this kind of evolutionary approach and comprehensive data sharing is completely unique to the ZBEdge suite of technologies. No one else is spending so much time looking at how we can use data to ensure that more patients are satisfied with their surgical results. I can see how they're pushing this forward — it's exciting and it makes you want to be part of it." n Thank you to James C. Ballard, MD for sharing his experiences with ZB Edge and the Zimmer Biomet suite of technologies. Dr. Ballard is a joint replacement specialist serving patients in Oregon City, Oregon, and the surrounding communities. Dr. Ballard is a Paid Zimmer Biomet consultant. *iPhone and Apple Watch are trademarks of Apple, Inc., registered in the US and other countries. Patients must have a compatible iPhone to use the mymobility mobile app; not all patients are suitable for therapy at home. References 1 Vizient. Outpatient Joint Replacement: An Unnecessary Concern or Market Reality? 2 Parratte, S., et al. Instability After Total Knee Arthroplasty. Journal of Bone Joint Surgery (America). 90(1): 184, 2008. Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.